Clinical Trials Logo

Filter by:
NCT ID: NCT01295099 Withdrawn - Keloid Scar Clinical Trials

Keloid Scarring: Treatment and Pathophysiology

Start date: n/a
Phase: Phase 4
Study type: Interventional

To clarify the mechanisms of Keloid scar formation. Elucidate the action and therapeutic value of 5-FU in Keloid scar treatment Identify the genetic link with Keloid scar formation. Quantify the psychological/social impact in keloid scarring patients

NCT ID: NCT01282645 Withdrawn - Craniotomy Clinical Trials

Case Series to Evaluate Patient Specific Implants (PSI) in Polyether Ether Ketone (PEEK) Performance After 2 Years

Start date: July 2011
Phase: N/A
Study type: Observational

The primary objective of this retrospective study is to evaluate the percentage of patients with device related adverse events (infection, rejection, dislocation, fracture of the implant) in the first 24 months after implantation.

NCT ID: NCT01277458 Withdrawn - HIV Clinical Trials

Ethnicity Data in HIV Positive Men Who Have Sex With Men

Start date: March 2011
Phase:
Study type: Observational

Are there differences between the way that non-White men who have sex with men living in London with HIV describe their own ethnicity and the way in which their ethnic group is recorded in NHS clinics? We aim to describe the way in which clinics in London currently record a patient's ethnic group. Without accurate data for an individual's ethnic group we are unable to draw meaningful conclusions about their experiences of HIV care. It may be the case that patients from particular ethnic groups require specific ways of monitoring and treating their HIV but without knowing if these people are in a particular group any services directed to them may be wasted or underused.

NCT ID: NCT01266811 Withdrawn - Multiple Myeloma Clinical Trials

A Phase 3 Study of Siltuximab or Placebo in Combination With Velcade and Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma

Start date: July 2011
Phase: Phase 3
Study type: Interventional

The purpose of this study is to determine if there is an improvement in progression-free survival (length of time during and after treatment in which a patient is living with a disease that does not get worse) when siltuximab is added to VELCADE and dexamethasone in subjects with relapsed or refractory multiple myeloma.

NCT ID: NCT01247103 Withdrawn - Healthy Volunteers Clinical Trials

Assessment of the Safety and Pharmacokinetics of Single and Multiple Oral Doses of AZD4316 in Healthy Subjects

Start date: December 2010
Phase: Phase 1
Study type: Interventional

The purpose of the study is to assess the safety, tolerability and pharmacokinetics of AZD4316 following oral administration of single and multiple doses to healthy volunteers.

NCT ID: NCT01246492 Withdrawn - Blood Glucose Clinical Trials

The Effect of Artificial Sweeteners on Blood Glucose Response

Start date: November 2010
Phase: N/A
Study type: Interventional

The purpose of this study is to determine whether the presece of the artificial sweeteners aspartame, saccharin and asceulfame-k affect the blood glucose responses to an orally incested glucose solution.

NCT ID: NCT01231451 Withdrawn - HIV Infection Clinical Trials

Depot Contraception With and Without Lopinavir/Ritonavir

Start date: December 2010
Phase: Phase 1
Study type: Interventional

DMPA (depot medroxyprogesterone acetate or the 'depot' injection) is a widely used contraception. It is popular in woman with HIV as it probably still works when you take HIV drugs. HIV drugs can increase or decrease the level of other drugs (e.g. contraceptives) in your bloodstream which may make them work less well or increase side effects. It is assumed that DMPA can be given with HIV drugs there are no studies proving this. The purpose of the study is to investigate whether an HIV drug combination containing lopinavir/ritonavir affects DMPA when they are taken at the same time.

NCT ID: NCT01207154 Withdrawn - Clinical trials for Known Difficult Intubation

Feasibility of Using Depth-of-sedation Measuring Equipment (BIS) to Guide Awake Fibreoptic Intubation

Start date: December 2010
Phase: N/A
Study type: Observational

The purpose of this study is to determine whether or not a device which measures depth of anaesthesia and sedation can be used to assist in the sedation of patients who must have breathing tubes positioned in their airways before general anaesthesia

NCT ID: NCT01176318 Withdrawn - Clinical trials for Chronic Obstructive Pulmonary Disease

Erdosteine (Erdotin) Versus Standard Care Plus Placebo on Erdosteine for Treatment of Cough in Acute Exacerbations of Chronic Obstructive Pulmonary Disease (COPD)

Start date: August 10, 2010
Phase: Phase 4
Study type: Interventional

This is a parallel group, double-blind, placebo controlled, multi-centre, randomised trial. 60 patients to be included who are adult patients admitted to hospital with a clinical diagnosis of acute exacerbation of Chronic Obstructive Pulmonary Disease (COPD). Acute exacerbation of COPD will be defined as sustained worsening of the patient's condition with an increase in cough and one or more of dyspnoea, sputum volume or sputum purulence, necessitating a change in regular medication. The primary objective of this study is to evaluate the effectiveness of standard care plus erdosteine in reducing hourly cough (24 hour cough recording using automated cough recorder) measured from baseline (Day 0) and at Day 5 of treatment, compared with standard care plus placebo.

NCT ID: NCT01174316 Withdrawn - Clinical trials for Chronic Obstructive Pulmonary Disease

Autotitrating Versus Standard Non-invasive Ventilation (NIV) in Acute Exacerbation of Respiratory Failure

Start date: August 2010
Phase: N/A
Study type: Interventional

The aim of the study is to compare the efficacy and tolerance of autotitrating non-invasive ventilation (NIV) versus standard NIV in patients admitted to hospital with acute exacerbation of chronic respiratory failure. The investigators hypothesise that autotitrating NIV will ventilate patients with acute exacerbations of chronic respiratory failure as effectively as standard NIV.